Not yet recruitingNot applicableNCT07176117

Surfactant Using a Supraglottic Airway Device in Late Preterm to Early Term Infants

Studying Infant acute respiratory distress syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sharp HealthCare
Principal Investigator
Anup Katheria, MD
Sharp HealthCare
Intervention
Surfactant Administration Through Laryngeal or Supraglottic Airway (SALSA)(procedure)
Enrollment
422 enrolled
Eligibility
All sexes
Timeline
20252031

Study locations (3)

Collaborators

Chiesi USA, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07176117 on ClinicalTrials.gov

Other trials for Infant acute respiratory distress syndrome

Additional recruiting or active studies for the same condition.

See all trials for Infant acute respiratory distress syndrome

← Back to all trials